| Literature DB >> 32819384 |
Xin Wang1,2, Honglin Wang2, Tingting Li3, Feifei Liu1, Yiluo Cheng2, Xiaodong Guo2, Guoyuan Wen2, Qingping Luo2, Huabin Shao2, Zishu Pan4, Tengfei Zhang5.
Abstract
BACKGROUND: Salmonella is an important zoonotic pathogen, and chickens are one of its main hosts. Every year, Salmonella infections pose a serious threat to the poultry industry in developing countries, especially China. In this study, a total of 84 Salmonella isolates recovered from sick and healthy-looking chickens in central China were characterized by serotyping, MLST-based strain typing, presence of potential virulence factors, and antimicrobial resistance profiles. RESULT: Data showed that the main serotypes of Salmonella isolates in central China were Salmonella enterica serovar Gallinarum biovar Pullorum, Salmonella enterica serovar Gallinarum biovar Gallinarum, Salmonella enterica serovar Enteritidis and Salmonella enterica serovar Typhimurium, and among them, S. Pullorum was the dominant type in both sick and healthy-looking chickens, accounting for 43.9 and 46.5%, respectively, while S. Enteritidis was only found in healthy-looking chickens. All isolates exhibited higher resistance rates to ampicillin (97.6%), tetracycline (58.3%) and colistin (51.2%), and among these isolates, 49.5% were resistant to more than three drugs in different combinations. S. Enteritidis was the most severe multidrug-resistant serotype, which showed higher resistance rates to colistin, meropenem and ciprofloxacin. Multilocus sequence typing (MLST) revealed that S. Gallinarum and S. Enteritidis isolates were clustered in clade 1, which belonged to two and one STs, respectively. All S. Typhimurium isolates were clustered in clade 3, and belonged to three STs. However, S. Pullorum were distributed in three clades, which belonged to 7 STs. Twenty-seven virulence-associated genes were detected, and expected cdtB, which was absent in all the isolates, the other 26 genes were conserved in the closely related Salmonella serogroup D (S. Enteritidis, S. Pullorum, and S. Gallinarum).Entities:
Keywords: Antimicrobial resistance; Chicken; Multilocus sequence typing; Salmonella; Virulence-associated genes
Mesh:
Substances:
Year: 2020 PMID: 32819384 PMCID: PMC7441611 DOI: 10.1186/s12917-020-02513-1
Source DB: PubMed Journal: BMC Vet Res ISSN: 1746-6148 Impact factor: 2.741
Numbers and serotypes of Salmonella isolated from healthy-looking and sick chickens
| Serotypes | Others | Total | ||||
|---|---|---|---|---|---|---|
| healthy-lookinga | 14 | 2 | 5 | 20 | 2 | 43 |
| sickb | 0 | 9 | 11 | 18 | 3 | 41 |
| Total | 14 | 11 | 16 | 38 | 5 | 84 |
aHealthy-looking chicken; bsick and dead chicken
No. of isolates in different MICs and antimicrobial resistance of Salmonella isolates (n = 84)
| No. of isolates in different MICs & resistance rates | ||||||||||||||||||||
| Serotypes | Ampicillin | Cefotaxime | Meropenem | Gentamicin | Tetracycline | |||||||||||||||
| ≤8 | 16 | ≥32 | ≤1 | 2 | ≥4 | ≤1 | 2 | ≥4 | ≤4 | 8 | ≥16 | ≤4 | 8 | ≥16 | ||||||
| SEa(14) | 0 | 0 | 14 | 100.0 | 14 | 0 | 0 | 0.0 | 8 | 1 | 5 | 35.7 | 14 | 0 | 0 | 0.0 | 0 | 1 | 13 | 92.9 |
| STb(11) | 0 | 0 | 11 | 100.0 | 11 | 0 | 0 | 0.0 | 5 | 5 | 1 | 9.1 | 11 | 0 | 0 | 0.0 | 6 | 2 | 3 | 27.3 |
| SGc(16) | 2 | 0 | 14 | 87.5 | 7 | 5 | 4 | 25.0 | 16 | 0 | 0 | 0.0 | 13 | 3 | 0 | 0.0 | 2 | 1 | 13 | 81.3 |
| SGPd(38) | 0 | 0 | 38 | 100.0 | 33 | 3 | 2 | 5.3 | 34 | 4 | 0 | 0.0 | 35 | 2 | 1 | 2.6 | 22 | 0 | 16 | 42.1 |
| OTe(5) | 0 | 0 | 5 | 100.0 | 4 | 1 | 0 | 0.0 | 3 | 2 | 0 | 0.0 | 5 | 0 | 0 | 0.0 | 1 | 0 | 4 | 80.0 |
| Total(84) | 82 | 97.6 | 6 | 7.1 | 6 | 7.1 | 1 | 1.2 | 49 | 58.3 | ||||||||||
| No of isolates in different MICs & resistance rates | ||||||||||||||||||||
| Subspecies | Tigecycline | Chloramphenicol | Ciprofloxacin | Trimethoprim-sulfamethoxazole | Colistin | |||||||||||||||
| ≤2 | 4 | ≥8 | ≤8 | 16 | ≥32 | ≤1 | 2 | ≥4 | ≤2/38 | – | ≥4/76 | ≤2 | 4 | ≥8 | ||||||
| SEa(14) | 14 | 0 | 0 | 0.0 | 8 | 1 | 5 | 35.7 | 8 | 2 | 4 | 28.6 | 7 | 0 | 7 | 50.0 | 2 | 3 | 9 | 64.3 |
| STb(11) | 9 | 2 | 0 | 0.0 | 6 | 1 | 4 | 36.4 | 10 | 0 | 1 | 9.1 | 7 | 0 | 4 | 36.4 | 4 | 4 | 3 | 27.3 |
| SGc(16) | 13 | 2 | 1 | 6.3 | 7 | 0 | 9 | 56.3 | 16 | 0 | 0 | 0.0 | 14 | 0 | 2 | 12.5 | 5 | 6 | 5 | 31.3 |
| SGPd(38) | 33 | 2 | 3 | 7.9 | 27 | 2 | 9 | 23.7 | 35 | 3 | 0 | 0.0 | 32 | 0 | 6 | 15.8 | 5 | 10 | 23 | 60.5 |
| OTe(5) | 5 | 0 | 0 | 0.0 | 3 | 0 | 2 | 40.0 | 4 | 1 | 0 | 0.0 | 4 | 0 | 1 | 20.0 | 2 | 0 | 3 | 60.0 |
| Total(84) | 4 | 4.8 | 29 | 34.5 | 5 | 6.0 | 20 | 23.8 | 43 | 51.2 | ||||||||||
aS. Enteritidis; bS. Typhimurium; cS. Gallinarum; dS. Pullorum; eother serotypes;
Escherichia coli ATCC 25922 was the quality control, the detailed results are as follows, ampicillin (8 μg/ml), cefotaxime (0.12 μg/ml), meropenem (< 0.125 μg/ml), gentamicin (1 μg/ml), tetracycline (1 μg/ml), tigecycline (0.25 μg/ml), chloramphenicol (4 μg/ml), ciprofloxacin (0.015 μg/ml), trimethoprim-sulfamethoxazole (0.5/9.5 μg/ml) and colistin (2 μg/ml)
Resistance patterns among the 84 Salmonella isolates
| Resistance patternsa | Prevalence, (n) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SE | ST | SG | SGP | OT | total | |||||||
| AMP | 0 | 3 | 2 | 7 | 1 | 13 | ||||||
| TCY | 0 | 0 | 1 | 0 | 0 | 1 | ||||||
| AMP | TCY | 1 | 1 | 1 | 5 | 1 | 9 | |||||
| AMP | CLS | 0 | 2 | 0 | 6 | 0 | 8 | |||||
| AMP | TGC | 0 | 0 | 0 | 1 | 0 | 0 | |||||
| AMP | CHL | 0 | 0 | 0 | 1 | 0 | 1 | |||||
| AMP | CHL | CLS | 0 | 0 | 0 | 2 | 0 | 2 | ||||
| AMP | CHL | STX | 0 | 2 | 0 | 0 | 0 | 2 | ||||
| AMP | MEM | CHL | 0 | 1 | 0 | 0 | 0 | 1 | ||||
| AMP | MEM | TCY | 1 | 0 | 0 | 0 | 0 | 1 | ||||
| AMP | TCY | CLS | 3 | 0 | 0 | 3 | 1 | 7 | ||||
| AMP | TCY | STX | 1 | 1 | 1 | 0 | 0 | 3 | ||||
| AMP | STX | CLS | 0 | 0 | 0 | 4 | 0 | 4 | ||||
| AMP | TCY | CHL | 0 | 0 | 3 | 1 | 0 | 4 | ||||
| AMP | CHL | STX | CLS | 1 | 0 | 0 | 0 | 0 | 1 | |||
| AMP | CTX | TCY | CHL | 0 | 0 | 2 | 0 | 0 | 2 | |||
| AMP | MEM | TCY | CLS | 1 | 0 | 0 | 0 | 0 | 1 | |||
| AMP | TCY | CHL | CLS | 0 | 0 | 2 | 3 | 1 | 6 | |||
| AMP | TCY | STX | CLS | 0 | 0 | 1 | 1 | 0 | 2 | |||
| AMP | TCY | CLS | TGC | 0 | 0 | 0 | 1 | 0 | 0 | |||
| AMP | GEN | STX | CLS | TGC | 0 | 0 | 0 | 1 | 0 | 1 | ||
| AMP | CTX | TCY | CHL | CLS | 0 | 0 | 1 | 2 | 0 | 3 | ||
| AMP | MEM | TCY | STX | CLS | 1 | 0 | 0 | 0 | 0 | 1 | ||
| AMP | TCY | CHL | CIP | STX | 2 | 0 | 0 | 0 | 0 | 2 | ||
| AMP | MEM | TCY | CHL | CLS | 1 | 0 | 0 | 0 | 0 | 1 | ||
| AMP | TCY | CHL | STX | CLS | 0 | 0 | 0 | 0 | 1 | 1 | ||
| AMP | TCY | CIP | STX | CLS | 1 | 0 | 0 | 0 | 0 | 1 | ||
| AMP | CTX | TCY | CHL | CLS | TGC | 0 | 0 | 1 | 0 | 0 | 0 | |
| AMP | TCY | CHL | CIP | STX | CLS | 0 | 1 | 0 | 0 | 0 | 1 | |
| AMP | MEM | TCY | CHL | CIP | STX | CLS | 1 | 0 | 0 | 0 | 0 | 1 |
aResistance breakpoints were gentamicin (GEN; ≥ 16 μg/mL), meropenem (MEM; ≥ 4 μg/mL), ampicillin (AMP; ≥ 32 μg/mL), cefotaxime (CTX; ≥ 4 μg/mL), colistin (CLS; ≥8 μg/mL), ciprofloxacin (CIP; ≥ 4 μg/mL), chloramphenicol (CHL; ≥ 32 μg/mL), tigecycline (TGC; ≥ 8 μg/mL), compound sulfamethoxazole (SXT; ≥4/76 μg/mL), and tetracycline (TCY; ≥ 16 μg/mL) (Clinical and Laboratory Standards Institute, 2017)
Fig. 1Multilocus sequence typing minimum evolution tree of the Salmonella isolates
Prevalence of virulence-associated genes in avian Salmonella spp.
| Gene | Others | Total (%) | ||||
|---|---|---|---|---|---|---|
| ( | ( | ( | ( | ( | ||
| • | • | • | • | 4 | 98.8 | |
| • | • | • | • | • | 100 | |
| • | • | • | • | • | 100 | |
| • | • | • | • | • | 100 | |
| • | • | • | • | • | 100 | |
| ° | ° | ° | ° | ° | 0 | |
| • | • | • | • | • | 100 | |
| • | • | • | • | • | 100 | |
| • | • | • | • | • | 100 | |
| • | • | • | • | • | 100 | |
| • | • | • | • | • | 100 | |
| • | • | • | • | • | 100 | |
| • | • | • | • | • | 100 | |
| • | • | • | • | • | 100 | |
| • | • | • | • | • | 100 | |
| • | • | • | • | • | 100 | |
| • | • | • | • | • | 100 | |
| • | • | • | • | • | 100 | |
| • | 10 | • | • | • | 98.8 | |
| • | • | • | • | • | 100 | |
| • | • | • | • | • | 100 | |
| • | • | • | • | • | 100 | |
| • | • | • | • | • | 100 | |
| • | • | • | • | • | 100 | |
| • | • | • | • | • | 100 | |
| • | • | • | • | • | 100 | |
| • | 9 | • | • | 4 | 96.4 |
• indicates the presence of the gene;
° indicates that the gene does not exist